Introducing Fierce Biotech's 2026 Fierce 15
📍 Aftermath
{ "epilogue": "Fierce Biotech, a division of Forge, introduced its 2026 'Fierce 15' list naming innovative and promising private biotech companies. The coverage highlighted selected recipients including SonoThera, Beacon Therapeutics, Infinimmune, Sironax, and ReproNovo.
Following these announcements, the story quieted without a definitive conclusion in the coverage." }
Epilogue added 45d ago, after coverage quieted.
Where it stands
- Velocity & Diffusion: Coverage escalated across 6 distinct news outlets with 7 published articles, achieving a live velocity of 21.
- Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.
"Introducing Fierce Biotech's 2026 Fierce 15" developed substantial multi-source reporting across the Business sector, tracked across 6 distinct newsrooms by Newsylist.
Key reporting was led by BioSpace, Yahoo Finance, Voice of Alexandria and The Manila Times. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.
Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 45d ago.
Cross-Outlet Coverage & Framing Matrix
| Newsroom | Timeline Offset | Headline Framing | Source |
|---|---|---|---|
| Fierce Biotech | Origin | Introducing Fierce Biotech's 2026 Fierce 15 | Read report ↗ |
| Yahoo Finance | Origin | Fierce Biotech, a Division of Forge, Names SonoThera a "Fierce 15" Biotech Company of 2026 | Read report ↗ |
| globenewswire.com | Origin | FIERCE BIOTECH NAMES REPRONOVO A “FIERCE 15” BIOTECH COMPANY OF 2026 | Read report ↗ |
| The Manila Times | Origin | Sironax Named to Fierce Biotech’s 'Fierce 15” List of the Most Innovative and Promising Private Biotechs of 2026 | Read report ↗ |
| Voice of Alexandria | Origin | Fierce Biotech, a division of Forge, names Infinimmune a “Fierce 15” Biotech Company of 2026 | Read report ↗ |
| BioSpace | Origin | Fierce Biotech, a Division of Forge, Names SonoThera a “Fierce 15” Biotech Company of 2026 | Read report ↗ |
Sources (7)
-
-
-
-
-
-
-
Introducing Fierce Biotech's 2026 Fierce 15 Fierce Biotech · 48d ago broke it first
Answered
What drove coverage for Introducing Fierce Biotech's 2026 Fierce 15?
Coverage spiked when 6 independent newsrooms published 7 verified reports during this coverage cycle.
How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.
People, places & organizations
Related trends
Broadcom AI outlook in focus beyond quarterly results, Goldman says (AVGO:NASDAQ)
"Broadcom AI outlook in focus beyond quarterly results, Goldman says (AVGO:NASDAQ)" developed substantial multi-source reporting across the Business sector,…
Jeff Bezos donated $198.9 million in Amazon stock in two days, including shares he's held since 1994
"Jeff Bezos donated $198.9 million in Amazon stock in two days, including shares he's held since 1994" developed substantial multi-source reporting across the…
Employees at Eric Trump-backed robot startup lose health benefits as company's cash crunch deepens
"Employees at Eric Trump-backed robot startup lose health benefits as company's cash crunch deepens" developed substantial multi-source reporting across the…
China Lowers Margin Requirement to 80% to Boost Stock Liquidity
"China Lowers Margin Requirement to 80% to Boost Stock Liquidity" developed substantial multi-source reporting across the Business sector, tracked across 5…
AMD vs. Nvidia: Which AI Chip Stock Is the Better Buy on the Dip?
"AMD vs. Nvidia: Which AI Chip Stock Is the Better Buy on the Dip?" developed substantial multi-source reporting across the Business sector, tracked across 5…
Eli Lilly’s Next Weight-Loss Drug Helped Patients Lose Up to 54 Pounds. Why the FDA’s New Warning Didn’t Hurt LLY Stock.
"Eli Lilly’s Next Weight-Loss Drug Helped Patients Lose Up to 54 Pounds. Why the FDA’s New Warning Didn’t Hurt LLY Stock." developed substantial multi-source…